{"id":"isotretinoin-capsules","safety":{"commonSideEffects":[{"rate":"90","effect":"Cheilitis (lip inflammation)"},{"rate":"80","effect":"Dry skin and mucous membranes"},{"rate":"25-40","effect":"Elevated triglycerides"},{"rate":"15-20","effect":"Elevated liver enzymes"},{"rate":"10-15","effect":"Headache"},{"rate":"10","effect":"Photosensitivity"},{"rate":"null","effect":"Teratogenicity (if exposed during pregnancy)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Isotretinoin is a highly effective vitamin A derivative that acts on sebaceous glands to dramatically reduce sebum production and normalize keratinization. It also has anti-inflammatory and antimicrobial effects on Cutibacterium acnes (formerly Propionibacterium acnes). The drug can induce long-term remission or cure of severe acne by fundamentally altering the pathogenic factors involved in acne formation.","oneSentence":"Isotretinoin is a potent retinoid that reduces sebaceous gland size and sebum production while normalizing epithelial cell differentiation in the skin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:54.012Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe recalcitrant nodular acne"},{"name":"Acne at high risk of permanent scarring"}]},"trialDetails":[{"nctId":"NCT07228481","phase":"PHASE4","title":"Study of Two Dosages of Roaccutane in Cystic Acne","status":"COMPLETED","sponsor":"Premier Specialists, Australia","startDate":"2001-06-26","conditions":"Acne Cystic","enrollment":91},{"nctId":"NCT07012811","phase":"PHASE4","title":"Treatment of Plane Warts With Topical and Oral Retinoids","status":"COMPLETED","sponsor":"Tishreen University","startDate":"2024-02-12","conditions":"Plane Warts","enrollment":39},{"nctId":"NCT06451237","phase":"PHASE3","title":"Acne Remission Maintenance by Weekend Systemic Isotretinoin","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2018-01-20","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT06378983","phase":"NA","title":"Clinical Trial of Microneedle Radiofrequency Combined With Oral Isotretinoin in Moderate to Severe Acne","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2022-09-01","conditions":"Moderate to Severe Acne Vulgaris","enrollment":100},{"nctId":"NCT04940767","phase":"PHASE4","title":"A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Edward Lain, MD","startDate":"2021-06-28","conditions":"Acne Vulgaris","enrollment":31},{"nctId":"NCT03370367","phase":"PHASE3","title":"Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1989-05-15","conditions":"Stage I-II Head and Neck Cancer","enrollment":189},{"nctId":"NCT02795143","phase":"NA","title":"Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2016-11","conditions":"Toxic Epidermal Necrolysis","enrollment":""},{"nctId":"NCT03291080","phase":"PHASE1, PHASE2","title":"Oral Liquid 13-cis-retinoic Acid (13-CRA)","status":"COMPLETED","sponsor":"Nova Laboratories Limited","startDate":"2018-04-17","conditions":"Neuroblastoma","enrollment":20},{"nctId":"NCT05077813","phase":"PHASE2","title":"Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-12","conditions":"Tuberculosis","enrollment":250},{"nctId":"NCT05016349","phase":"PHASE3","title":"Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.","status":"UNKNOWN","sponsor":"Mahmoud Ramadan mohamed Elkazzaz","startDate":"2021-08","conditions":"Breast Cancer Female","enrollment":160},{"nctId":"NCT04353180","phase":"PHASE3","title":"Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-08","conditions":"COVID19","enrollment":100000},{"nctId":"NCT02457520","phase":"PHASE4","title":"ABSORICA in Patients With Severe Recalcitrant Nodular Acne","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2015-01-21","conditions":"Acne","enrollment":201},{"nctId":"NCT01474590","phase":"PHASE3","title":"Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-11","conditions":"Acne","enrollment":266},{"nctId":"NCT04361422","phase":"PHASE3","title":"Isotretinoin in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2020-12-01","conditions":"COVID-19","enrollment":300},{"nctId":"NCT04290572","phase":"PHASE3","title":"Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts","status":"UNKNOWN","sponsor":"Centro Dermatológico Dr. Ladislao de la Pascua","startDate":"2020-03-15","conditions":"Flat Wart","enrollment":162},{"nctId":"NCT04204304","phase":"NA","title":"Relationship Between Serum Vitamin D Levels and Musculoskeletal Adverse Effects in Patients Using Isotretinoin","status":"COMPLETED","sponsor":"Ankara Training and Research Hospital","startDate":"2019-03-15","conditions":"Musculoskeletal Disease Other, Isotretinoin Adverse Reaction, Vitamin D Deficiency","enrollment":177},{"nctId":"NCT03026946","phase":"PHASE3","title":"Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2017-05-29","conditions":"Hand Eczema","enrollment":76},{"nctId":"NCT03026907","phase":"PHASE3","title":"Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2016-05","conditions":"Hand Eczema","enrollment":116},{"nctId":"NCT01863615","phase":"PHASE1","title":"Bioequivalence Study for an Isotretinoin","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-08-26","conditions":"Skin Infections (Acne)","enrollment":36},{"nctId":"NCT02498288","phase":"PHASE1","title":"A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-05-31","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT01048086","phase":"PHASE2","title":"90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)","status":"WITHDRAWN","sponsor":"University of Iowa","startDate":"2009-06","conditions":"Neuroblastoma, Neuroendocrine Tumor","enrollment":""},{"nctId":"NCT01208454","phase":"PHASE1","title":"Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-12","conditions":"Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma","enrollment":29},{"nctId":"NCT01891526","phase":"","title":"Single Dose of 9-cis-retinoic Acid in Hepatic Patients","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2010-12","conditions":"Hepatic Insufficiency","enrollment":20},{"nctId":"NCT01888289","phase":"PHASE1","title":"Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2001-07","conditions":"Healthy","enrollment":35},{"nctId":"NCT01888328","phase":"PHASE1","title":"Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2001-05","conditions":"Healthy","enrollment":26},{"nctId":"NCT01888341","phase":"PHASE1","title":"Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2002-08","conditions":"Healthy","enrollment":41},{"nctId":"NCT01888224","phase":"PHASE1","title":"Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2011-06","conditions":"Healthy","enrollment":61},{"nctId":"NCT01261923","phase":"PHASE1, PHASE2","title":"Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2010-12","conditions":"Hepatic Insufficiency","enrollment":16},{"nctId":"NCT01139749","phase":"PHASE4","title":"Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2011-10","conditions":"Seborrhea, Seborrheic Dermatitis, Quality of Life","enrollment":50},{"nctId":"NCT00842907","phase":"PHASE2","title":"Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2009-05","conditions":"Photodamage, Photoaging","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Oral retinoid","Adapalene gel"],"phase":"phase_3","status":"active","brandName":"Isotretinoin capsules","genericName":"Isotretinoin capsules","companyName":"Centro Dermatológico Dr. Ladislao de la Pascua","companyId":"centro-dermatol-gico-dr-ladislao-de-la-pascua","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Isotretinoin is a potent retinoid that reduces sebaceous gland size and sebum production while normalizing epithelial cell differentiation in the skin. Used for Severe recalcitrant nodular acne, Acne at high risk of permanent scarring.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}